Search
for
Sort by
Research 421–450 of 524
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Emerging treatments in alopecia
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- 1310 Anti-aging effects of retinoid hydroxypinacolone retinoate on skin models
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Nanotecnología en Tricología: Avances Terapéuticos y Perspectivas Futuras en el Tratamiento de las Alopecias
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Journal of Population Therapeutics and Clinical Pharmacology
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Molecular Mechanisms Affecting Development of Animal Fibers and Some Studies on Goats
- Líquen plano pilar e alopecia frontal fibrosante: correlação dos achados clínicos e dermatoscópicos com o grau de inflamação do exame histopatológico
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- 1314 Advanced age impairs self-renewal and biases fate choice of hair follicle dermal stem cells